Sotac Pharmaceuticals Ltd

NSE: SOTAC · Other · sector

₹92.00NSE close 2026-10-21

Key numbers

Market cap₹102 cr

Price₹92.00

52w high / low₹140 / ₹86

P/E17.6xSector median 14.4x

P/B2.1xSector median 1.7x

Book value₹43.3

Dividend yield0.11%Sector median 0.37%

ROE12.8%Sector median 13.8%

ROCE26.8%Sector median 19.6%

OPM17.7%Sector median 10.4%

Debt / equity–Sector median 0.29x

EV/EBITDA5.6xSector median 8.4x

Interest cover3.1x

Current ratio1.33x

Sales growth 3y–Sector median +7.7%

Profit growth 3y–Sector median +16.6%

PEG–

Last 12 months to Mar 2026, Consolidated. "Sector median" = middle value of 688 companies in Other (P/E median leaves out loss-making companies). Tap ? for what a number means.

Things to know

Operating profit covered interest 3.1x in the last 12 months.
Operating cash flow was below net profit in 2 of the last 3 years (FY25, FY24).
Other income was 6% of net profit in the last 12 months.
No dividend in the last 3 financial years.
Price ₹92.00 on 2026-10-21: -34.1% from the 52-week high, +7.0% from the 52-week low.

Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.

Charts

Weekly close · high ₹150.00 · low ₹90.05

Quarterly results

₹ cr	Sep 2023	Mar 2024	Sep 2024	Mar 2025	Sep 2025	Mar 2026
Revenue	52	52	53	44	37	60
EBITDA	4	4	4	9	4	10
OPM %	8.6%	7.4%	8.2%	21.0%	9.8%	16.8%
Other income	0	0	1	3	4	0
Net profit	2	3	2	6	2	3
EPS (₹)	1.10	2.80	1.73	5.53	2.21	3.01
Revenue YoY					-28.3%	+15.1%
Profit YoY					+41.6%	+30.2%

Consolidated figures where filed. Latest quarter Mar 2026.

Profit & loss (yearly)

₹ cr	FY24	FY25	FY26	TTM
Revenue	104	97	101	101
EBITDA	8	14	18	18
Net profit	4	8	6	6
EPS (₹)	3.90	7.26	5.22	5.22
Revenue growth		-6.6%	+4.4%	–
Profit growth		+87.6%	-28.1%	–
Dividend / share (₹)	–	–	–

Compounded growth	3 years	5 years	Last 12 months
Sales	–	–	–
Net profit	–	–	–
EPS	–	–	–
Share price	–	-20.1% (2y)	-26.4%

Balance sheet

₹ cr	FY24	FY25	FY26
Shareholders' equity	–	42	48
Cash & equivalents	–	2	1
Total assets	–	124	133
Fixed assets	–	47	46
Investments	–	4	3
Inventory	–	20	27

Year-end figures from the March annual filing.

Cash flow

₹ cr	FY24	FY25	FY26
Cash from operations	-16	-4	17
Cash from investing	-20	-14	-7
Cash from financing	30	16	-10
Capex	15	17	6
Free cash flow	-31	-21	10

Free cash flow = cash from operations − capex.

Ratios by year

₹ cr	FY24	FY25	FY26
ROE %	–	19.0%	12.1%
ROCE %	–	32.5%	26.8%
Inventory days	–	108	153
Working capital days	–	69	70

Peers in Other

Company	Market cap	P/E	P/B	ROE	ROCE	OPM	Sales 3y	Div yield
TSFINV	₹8,585 cr	17.6x	1.4x	8.4%	3.6%	20.5%	+121.7%	2.30%
KRISHANA	₹6,339 cr	39.9x	11.3x	41.6%	23.2%	12.6%	+95.7%	0.05%
MARINE	₹5,431 cr	84.2x	11.0x	14.3%	18.0%	10.8%	+25.6%	0.07%
ZOTA	₹4,139 cr	–	6.0x	-22.5%	-12.4%	-0.5%	+56.7%	0.07%
AIMTRON	₹3,319 cr	71.7x	17.1x	28.0%	31.8%	21.8%	–	–
ACCORD	₹2,984 cr	–	261.7x	12.4%	12.0%	2.4%	–	–
MONOLITH	₹2,646 cr	64.6x	24.3x	36.0%	48.7%	24.4%	–	–
UTSSAV	₹2,390 cr	40.2x	14.1x	43.4%	54.7%	7.9%	–	–
BETA	₹2,200 cr	40.6x	5.0x	16.4%	17.0%	20.8%	–	–
SOTAC	₹102 cr	17.6x	2.1x	12.8%	26.8%	17.7%	–	0.11%

All 688 companies in Other →

Documents

Links go to the original files on the exchange website.

About the company


Sector
Industry	Other
Sub-industry
Symbol	SOTAC
BSE code	–
ISIN	INE0O2D01012
Face value	₹10.0
Incorporated	–
Website	–
Plants (India / abroad)	–

Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results); price = NSE close 2026-10-21.